神农科技(300189) - 2021 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2021 was ¥36,826,602.08, representing a 73.21% increase compared to ¥21,261,694.62 in the same period last year[8]. - The net profit attributable to shareholders was -¥405,687.61, showing a 90.22% improvement from -¥4,149,156.66 year-on-year[8]. - The net cash flow from operating activities was ¥4,346,136.10, a significant increase of 158.33% compared to -¥7,450,372.39 in the previous year[8]. - The company achieved operating revenue of ¥36,826,602.08, a year-on-year increase of 73.21%[17]. - Net profit loss was reduced by 72.38% to -¥1,204,029.72, with the net profit attributable to shareholders of the parent company at -¥405,687.61, a reduction of 90.22%[17]. - Total operating revenue for Q1 2021 was CNY 36,826,602.08, an increase of 73% compared to CNY 21,261,694.62 in the same period last year[56]. - Total operating costs for Q1 2021 were CNY 49,506,943.56, up 78% from CNY 27,839,435.39 year-over-year[56]. - Net loss for Q1 2021 was CNY 1,204,029.72, a reduction in loss compared to CNY 4,359,483.22 in Q1 2020[58]. - Operating profit for Q1 2021 was CNY -7,366,553.98, worsening from CNY -4,393,072.95 in the previous year[56]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,133,948,964.85, reflecting a 2.58% increase from ¥1,105,393,533.35 at the end of the previous year[8]. - The company’s total assets reached ¥1,133,948,964.85, a growth of 2.58% compared to the previous year[17]. - Current assets totaled CNY 386,181,938.49, up from CNY 369,986,877.58, indicating an increase of about 4.5%[50]. - The company's cash and cash equivalents increased to CNY 226,879,595.46 from CNY 203,433,539.63, reflecting a growth of approximately 11.5%[50]. - Total current liabilities rose to CNY 107,338,058.78 from CNY 77,950,598.33, marking an increase of around 37.8%[52]. - The total liabilities increased to CNY 126,397,807.77 from CNY 96,638,346.55, which is an increase of approximately 30.8%[52]. - The total equity attributable to shareholders decreased slightly to CNY 928,243,308.66 from CNY 928,648,996.27, a decline of about 0.04%[52]. - The company reported a net loss of CNY -391,366,181.16 as of March 31, 2021, compared to CNY -390,960,493.55 at the end of 2020, indicating a slight increase in losses[52]. - The company’s inventory decreased to CNY 31,495,510.44 from CNY 49,063,288.51, a reduction of approximately 35.7%[50]. - The company’s long-term investments remained stable at CNY 227,908,588.90, showing a minor decrease from CNY 228,398,521.39[51]. - The company’s fixed assets increased to CNY 254,792,719.43 from CNY 239,900,899.81, reflecting a growth of about 6.5%[51]. Shareholder Information - The total number of shareholders at the end of the reporting period was 86,719, with the top ten shareholders holding significant stakes[11]. - The largest shareholder, Cao Oujie, held 17.94% of the shares, totaling 183,666,101 shares[11]. - The company did not experience any changes in its total share capital due to new share issuance or other equity-related activities during the reporting period[8]. - A shareholder has agreed to transfer 52 million shares at a price of RMB 4.2 per share, totaling RMB 218.4 million, reducing their stake from 16% to 10.92%[36]. Research and Development - Research and development expenses rose by ¥2,535,200, an increase of 227.30%, reflecting higher investment in R&D after the consolidation[1]. - The company plans to enhance its research and development capabilities for superior varieties and shorten the development cycle for new varieties[28]. - Research and development expenses increased to CNY 3,650,600.62, up from CNY 1,115,374.58 in the same quarter last year, reflecting a focus on innovation[56]. Legal and Compliance - The company has initiated legal proceedings to dissolve Bolian Gene due to its ineffective governance structure and lack of operational activities[39]. - The company is involved in 11 other legal cases, with 1 case concluded and 3 cases already adjudicated but not executed[42]. - The company has no violations regarding external guarantees during the reporting period[44]. - There are no non-operational fund occupations by controlling shareholders or related parties during the reporting period[45]. - The company has not engaged in any share repurchase activities during the reporting period[43]. - The company has not reported any significant changes in net profit compared to the same period last year[44]. - The company has not conducted any investor communications or interviews during the reporting period[46]. Strategic Initiatives - The company plans to enhance market competitiveness by optimizing resource allocation and improving breeding efficiency through collaboration among subsidiaries[21]. - The company aims to explore new business development paths, focusing on the production and industrialization of health oils and functional rice varieties[22]. - The company intends to strengthen financing channels and improve fund management to meet operational funding needs[23]. - The company is adjusting its strategic planning to improve financial conditions by expanding revenue sources and reducing marketing costs[33]. - The company plans to transfer 100% equity of its wholly-owned subsidiary for no less than RMB 173 million, with a signed agreement for RMB 183 million[34]. Cash Flow and Investments - Total cash inflow from operating activities was CNY 97,269,409.46, compared to CNY 18,930,956.22 in the same period last year[63]. - The net cash flow from operating activities for the parent company was CNY 2,346,585.79, compared to a negative cash flow of CNY -1,134,389.89 in the previous period, indicating a significant improvement[66]. - Total cash and cash equivalents at the end of the period reached CNY 205,921,801.51, up from CNY 104,429,044.01 in the same period last year, reflecting a year-over-year increase of approximately 97%[66]. - The net cash flow from investment activities was CNY 21,010,319.51, compared to CNY 16,734,886.45 in the previous period, showing a growth of about 25.6%[66]. - The company reported cash outflows from investment activities of CNY 272,500,000.00, indicating a significant investment in growth initiatives[66]. - The company disposed of subsidiaries and other business units, receiving CNY 36,600,000.00, which is a significant increase from CNY 10,000,000.00 in the previous period[66]. - The cash flow from the disposal of fixed assets and other long-term assets was CNY 6,552,762.92, compared to CNY 0 in the previous period, indicating active asset management[66].